Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on October 15, 2009

Stroke. 2009
Published online before print October 15, 2009, doi: 10.1161/STROKEAHA.109.560854
A more recent version of this article appeared on December 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/12/3691    most recent
STROKEAHA.109.560854v2
STROKEAHA.109.560854v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Carvalho da Paixão, L.
Right arrow Articles by Teixeira, A. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carvalho da Paixão, L.
Right arrow Articles by Teixeira, A. L.
Related Collections
Right arrow Other diagnostic testing
Right arrow Acute myocardial infarction
Right arrow Acute Stroke Syndromes
Right arrow Epidemiology

Submitted on June 17, 2009
Revised on August 13, 2009
Accepted on September 2, 2009

Chagas Disease. Independent Risk Factor for Stroke

Leonardo Carvalho da Paixão MD*; Antonio Luiz Pinho Ribeiro MD; Reginaldo Aparecido Valacio MD; and Antonio Lucio Teixeira MD*

From the Odilon Behrens Hospital (L.C.d.P., R.A.V.) and the Infectious Diseases and Tropical Medicine Program (A.L.T., A.L.P.R.), Department of Internal Medicine, Federal University of Minas Gerais Faculdade de Medicina, Belo Horizonte, Brazil.

* To whom correspondence should be addressed. E-mail: leonardopaixao{at}yahoo.com.br or altexr{at}gmail.com.

Background and Purpose—It has been suggested that Chagas disease (CD) and particularly CD cardiomyopathy are independent risk factors for cerebrovascular events. Strong evidence is scarce, cardioembolic and inflammatory mechanisms have been proposed, and most studies lack representative and well-matched controls. We sought to investigate CD, defined by positive serology, as an independent risk factor for stroke, by comparing patients admitted with ischemic stroke with representative control patients with a very similar cardiovascular risk factor profile.

Methods—We performed a case-control study with 101 consecutive stroke patients and 100 consecutive acute coronary syndrome patients admitted to an emergency hospital. CD was investigated in all patients and was confirmed when both immunofluorescence and hemagglutination tests were positive. Clinical, laboratory, and ECG findings were analyzed.

Results—We found that age (P=0.006), female sex (P=0.01), systolic blood pressure (P=0.001), diastolic blood pressure (P=0.03), previous stroke/transient ischemic attack history (P<0.001), atrial fibrillation (P=0.005), other arrhythmias (P=0.05), and CD-positive serology (P=0.002) were more frequent among stroke patients than among patients with acute coronary syndromes. After a multivariable analysis with a backward elimination procedure, previous stroke/transient ischemic attack history (odds ratio=6.98; 95% CI, 2.99 to 16.29), atrial fibrillation (odds ratio=4.52; 95% CI, 1.45 to 14.04), and CD-positive serology (odds ratio=7.17; 95% CI, 1.50 to 34.19) remained independently associated with stroke.

Conclusions—CD seems to be an independent risk factor for ischemic stroke. For patients in or coming from endemic regions, CD should be considered an etiologic or contributing factor for stroke.


Key words: Chagas disease • American trypanosomiasis • stroke • risk factors • acute coronary syndrome